|
| Home : VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform |
|
Sep 23
2021 |
VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform |
|
LONDON, Sept. 23, 2021 /PRNewswire/ -- VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform originating from Imperial College London, today announces a collaboration with AstraZeneca to progress the company's... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/vaxequity-announces-strategic-collaboration-with-astrazeneca-to-commercialise-self-amplifying-rna-platform-301383005.html |
| |
|
Related News
|
» Lufax Releases First ESG Report Highlighting Commitment to Inclusive Finance
» Melvin Van Peebles, godfather of Black cinema, dies at 89
|
|
|
